Search results :

Emtricitabine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J05AF09

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Infection 44% x x x x
Skin hyperpigmentation postmarketing, 32% x x x x x x x
Cough increased 28% x x x x x x
Otitis media 23% x x x
Rhinitis 20% x x x x x x
Body temperature increased postmarketing, 18% x x x x x
Pneumonia 15% x x x x
Diarrhoea postmarketing — 5% - 20% x x x x x x x
Fasting 2% - 24% x x x x
Gastroenteritis 11% x x x
Abdominal pain postmarketing — 10% x x x x x x x
Rash postmarketing — 9% - 21% x x x x x x x
Fatigue 8% x x x x
Anaemia postmarketing — 7% - 9.5% x x x x x x x
Depression 7% x x x x
Dizziness postmarketing — 7% x x x x x x x
Nausea postmarketing — 7% - 10% x x x x x x x
Insomnia postmarketing — 7% x x x x x x x
Headache postmarketing — 5% - 10.2% x x x x x x x
Hyperbilirubinaemia postmarketing, common x x
Upper respiratory tract infection 5% x x x x
Vomiting postmarketing — 5% - 23% x x x x x x x
Alanine aminotransferase increased postmarketing, common x x x
Sinusitis 4% x x x x
Nasopharyngitis 3% x x x x
Asthenia postmarketing, common x x x x x x x
Dyspepsia postmarketing, common x x x x x x x
Hypersensitivity postmarketing, common x x x x
Hypertriglyceridaemia postmarketing, common x x
Neutropenia postmarketing, common x x
Pain postmarketing, common x x
Pruritus postmarketing, common x x x x
Urticaria postmarketing, common x x x x
Rash pustular postmarketing, common x x x x
Amylase increased postmarketing, common x x x
Vesiculobullous rash postmarketing, common x x x x
Abnormal dreams postmarketing, common x x x x x x x
Rash maculo-papular postmarketing, common x x x x
Haematuria 2% - 3% x x x x x
Glycosuria 1% x x x x
Hyperglycaemia postmarketing — 1% - 2% x x x x x x
Angioedema postmarketing, uncommon x x
Lactic acidosis postmarketing x x x x x x
Autoimmune disorder postmarketing x
Mental disorder postmarketing x x x x x x
Connective tissue disorder postmarketing x x
Gastrointestinal disorder postmarketing x x x x x x x
Basedow's disease postmarketing x
Hepatitis postmarketing x x
Hepatomegaly postmarketing x x x x x
Hypercholesterolaemia postmarketing x
Hypertrophy of breast postmarketing x
Immune system disorder postmarketing x x
Inflammation postmarketing x x x
Insulin resistance postmarketing x
Lipodystrophy postmarketing x
Nervous system disorder postmarketing x x x x x x
Opportunistic infection postmarketing x
Osteonecrosis postmarketing x
Pancreatitis postmarketing x x
Thrombocytopenia postmarketing x
Skin discolouration postmarketing — 31.8% x x x x x x x
Malnutrition postmarketing x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x
Function kidney decreased postmarketing x
Hepatobiliary disease postmarketing x x
Infection mixed postmarketing x x
Buffalo hump postmarketing x
Hyperlactacidaemia postmarketing x
Blood and lymphatic system disorders postmarketing x x
Renal impairment postmarketing x
Hepatic steatosis postmarketing x x
Anxiety x
Arthralgia x x x x x x
Back pain x
Breast disorder x
Anogenital warts x
Depressive disorder x x x x x
Dyspnoea x
Fanconi syndrome x
Fracture x
Hepatitis B x x x x
Hypokalaemia x
Renal failure acute x
Nephrosis lower nephron x
Mediastinal disorder x
Myopathy x
Nephritis interstitial x
Neuritis x x x x x x
Osteomalacia x
Paraesthesia x x x x x x
Neuropathy peripheral x
Pharyngitis x
Polyuria x
Proteinuria x
Prurigo x
Renal failure x
Rhabdomyolysis x
Syphilis x
Urethritis x
Urinary tract infection x
Urinary tract disorder x
Weight decreased x
Hypophosphataemia x
Secondary syphilis x
Genital ulceration x
Creatine phosphokinase increased x x x
Creatinine increased x
Muscular weakness x
Bone pain x
Haemoglobin decreased x x x x
Nephrogenic diabetes insipidus x
Rash macular x
Rash vesicular x
Myalgia x x x x x x
Blood creatinine increased x
Neuropathy x x x x x x
Rash generalised x
Lipase increased x x x
Infestation NOS x x x x
Glucose low x x x
Exfoliative rash x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

emtricitabine / emtricitabine

Side effects:55
Source:EMA

EMTRICITABINE / EMTRIVA

Side effects:36
Source:Health Canada

emtricitabine

Side effects:48
Source:FDA Structured Product Label

EMTRICITABINE

Side effects:50
Source:FDA Structured Product Label

emtricitabine / Emtriva

Side effects:59
Source:FDA

EMTRICITABINE

Side effects:85
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label